Detalhe da pesquisa
1.
A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study.
Diabetes Obes Metab;
26(6): 2248-2256, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38456558
2.
Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis.
Am J Nephrol;
54(9-10): 370-378, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37708857
3.
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study.
J Gastroenterol Hepatol;
38(9): 1598-1609, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37321651
4.
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study).
BMC Med;
20(1): 93, 2022 03 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35307033
5.
Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double-blind, and placebo-controlled study.
Diabetes Obes Metab;
24(6): 1105-1113, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35229427
6.
Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease.
Hepatobiliary Pancreat Dis Int;
21(3): 241-247, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35365418
7.
Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trial.
Diabetes Obes Metab;
23(2): 609-618, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33217092
8.
Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes.
Diabetes Obes Metab;
23(4): 1041-1051, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33394549
9.
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
Am J Gastroenterol;
115(4): 584-595, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32141917
10.
Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study.
Cardiovasc Diabetol;
19(1): 81, 2020 06 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32534588
11.
Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study.
Diabetologia;
62(5): 779-788, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30788528
12.
Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk.
Diabetes Obes Metab;
21(4): 801-811, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30407726
13.
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
J Hepatol;
68(4): 764-772, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29175242
14.
Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
J Gastroenterol Hepatol;
33(5): 1082-1091, 2018 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28990251
15.
Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
Hepatology;
63(3): 776-86, 2016 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26638128
16.
Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008-2011).
Cardiovasc Diabetol;
16(1): 54, 2017 04 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28441953
17.
The renal tubular damage marker urinary N-acetyl-ß-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Cardiovasc Diabetol;
16(1): 16, 2017 01 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28122570
18.
Differential association of body mass index on glycemic control in type 1 diabetes.
Diabetes Metab Res Rev;
33(1)2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27155402
19.
Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial.
Diabetes Obes Metab;
24(4): 752-756, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34918436
20.
Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice.
BMC Endocr Disord;
17(1): 68, 2017 Oct 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29065865